Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Current Oncology (Toronto, Ont.)
|
May 30, 2009
Targeted therapies for renal cell carcinoma: more gains from using them again
H K Gan, B Seruga, J J Knox
Current Oncology (Toronto, Ont.)
|
May 30, 2009
Managing toxicities and optimal dosing of targeted drugs in advanced kidney cancer
B Seruga, H K Gan, J J Knox
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 9, 2012
How valid are claims for synergy in published clinical studies?
A Ocana, E Amir, C Yeung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 10, 2009
Global drug development in cancer: a cross-sectional study of clinical trial registries
B Seruga, P C Hertz, L W Le, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 4, 2018
Hyperglycaemia and Survival in Solid Tumours: A Systematic Review and Meta-analysis
R Barua, A J Templeton, B Seruga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 27, 2012
Comparison of absolute benefits of anticancer therapies determined by snapshot and area methods
B Seruga, G R Pond, P C Hertz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2009
Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer
B Seruga, P C Hertz, L Wang, et al.
Cancer Treatment Reviews
|
February 2, 2016
Evolution in the eligibility criteria of randomized controlled trials for systemic cancer therapies
A Srikanthan, F Vera-Badillo, J Ethier, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 7, 2015
Impact of Geographic Region on Benefit of Approved Anticancer Drugs Evaluated in International Phase III Clinical Trials
H Y AlHashem, M Al-Mubarak, F E Vera-Badillo, et al.
Breast Cancer Research and Treatment
|
September 8, 2012
A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer
J Vardy, G Pond, A Dodd, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Current Oncology (Toronto, Ont.)
|
May 30, 2009
Targeted therapies for renal cell carcinoma: more gains from using them again
H K Gan, B Seruga, J J Knox
Current Oncology (Toronto, Ont.)
|
May 30, 2009
Managing toxicities and optimal dosing of targeted drugs in advanced kidney cancer
B Seruga, H K Gan, J J Knox
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 9, 2012
How valid are claims for synergy in published clinical studies?
A Ocana, E Amir, C Yeung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 10, 2009
Global drug development in cancer: a cross-sectional study of clinical trial registries
B Seruga, P C Hertz, L W Le, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 4, 2018
Hyperglycaemia and Survival in Solid Tumours: A Systematic Review and Meta-analysis
R Barua, A J Templeton, B Seruga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 27, 2012
Comparison of absolute benefits of anticancer therapies determined by snapshot and area methods
B Seruga, G R Pond, P C Hertz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2009
Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer
B Seruga, P C Hertz, L Wang, et al.
Cancer Treatment Reviews
|
February 2, 2016
Evolution in the eligibility criteria of randomized controlled trials for systemic cancer therapies
A Srikanthan, F Vera-Badillo, J Ethier, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 7, 2015
Impact of Geographic Region on Benefit of Approved Anticancer Drugs Evaluated in International Phase III Clinical Trials
H Y AlHashem, M Al-Mubarak, F E Vera-Badillo, et al.
Breast Cancer Research and Treatment
|
September 8, 2012
A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer
J Vardy, G Pond, A Dodd, et al.
Page
of 2